| Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer (NCT05436808) | Stony Brook University | 2022-07-15 |
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (NCT03936478) | University of Wisconsin, Madison | 2022-05-16 |
| The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing (NCT04916808) | PreludeDx | 2021-07-02 |
| Molecular Analysis of the Sloane Project (NCT05868252) | King's College London | 2020-03-01 |
| Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ (NCT04722692) | Uppsala University | 2020-03-01 |
| Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs (NCT04170920) | Indiana University | 2020-02-17 |
| Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients (NCT03931928) | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 2019-09-10 |
| Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer (NCT04084730) | Memorial Sloan Kettering Cancer Center | 2019-08-30 |
| Perioperative Mindfulness Proposal (NCT04049214) | Hoag Memorial Hospital Presbyterian | 2019-07-31 |
| Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast (NCT03878342) | UNICANCER | 2019-05-10 |
| Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity (NCT04245150) | Case Comprehensive Cancer Center | 2019-03-21 |
| Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery (NCT03535506) | Georgetown University | 2018-10-08 |
| The PREDICT Registry: (NCT03448926) | PreludeDx | 2018-02-27 |
| Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS (NCT02926911) | Alliance Foundation Trials, LLC. | 2017-02-22 |
| Management of Low-risk (Grade I and II) DCIS (NCT02492607) | The Netherlands Cancer Institute | 2017-02-13 |
| Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS (NCT02766881) | Ontario Clinical Oncology Group (OCOG) | 2016-08-01 |
| Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (NCT02637024) | Ontario Clinical Oncology Group (OCOG) | 2016-05-01 |
| CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (NCT02365714) | Georgetown University | 2015-02-01 |
| Tumor: Breast Ratio Study (NCT02216136) | Washington University School of Medicine | 2014-04-14 |
| Impact of Radiation Therapy on Breast Conservation in DCIS (NCT02248662) | Dana-Farber Cancer Institute | 2013-08-01 |
| DC Vaccine for Patients With Ductal Carcinoma In Situ (NCT02061332) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women (NCT00256217) | Rita Sanghvi, Mehta | 2004-09-21 |
| MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ (NCT00586326) | Hologic, Inc. | 2003-08-01 |
| Educational Interventions for Patients With DCIS (NCT00148655) | Dana-Farber Cancer Institute | 2003-05-01 |